Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078697485> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2078697485 abstract "It has been demonstrated that bombesin/GRP antagonist D-Tpi(6),Leu(13)psi(CH2NH) Leu(14)-BN(6-14) (RC-3095) inhibits effectively the growth of pancreatic cancer and other tumors in experimental animals and in cell cultures. In an attempt to develop antagonists with still greater antitumor activity, several new pseudononapeptide bombesin/GRP antagonists containing C-terminal Leu psi(CH2N)Tac-NH2 have been synthesized in our laboratory. In this study, we investigated the ability of four Leu(13)psi(CH2N)Tac(14)-BN(6-14) antagonists to inhibit the binding of bombesin to specific receptors for bombesin/GRP on CFPAC-1 human pancreatic cancer cells. Receptor binding assays were performed by incubating CFPAC-1 cells (5x10(4) cells/well) with 0.5 nM [I-125]-Tyr(4)-bombesin in the absence or presence of (1 pM to 10 mu M) unlabeled bombesin, GRP(14-27) and various antagonists for 2 h at 22 degrees C. Displacement assays showed that antagonist D-Tpi(6),Leu(13)psi(CH2N)Tac(14)-BN(6-14) (RC-3910-II) with a similar structure to RC-3095, but a different C-terminal, had a binding affinity to CFPAC-1 cells 15 times higher than RC-3095. Three other antagonists, RC-3925-II, RC-3940-II and RC-3950-II contained the same C-terminal Leu psi(CH2N)Tac-NH2 as RC-3910-II, but had different N-terminal residues: D-Cpa, Hca and D-Phe, respectively. Among them, Hca(6),Leu(13)psi(CH2N)Tac(14)-BN(6-14) (RC-3940-II) showed the highest binding affinity to the receptors on CFPAC-1 cells, which was 50 times higher than that of RC-3095 or 3 times greater than RC-3910-II. Our findings suggest the merit of further investigation of pseudononapeptide bombesin/GRP antagonist RC-3940-II ind related analogs for a possible development of a new hormonal therapy for pancreatic cancer." @default.
- W2078697485 created "2016-06-24" @default.
- W2078697485 creator A5015546244 @default.
- W2078697485 creator A5019624736 @default.
- W2078697485 creator A5068739269 @default.
- W2078697485 creator A5084448804 @default.
- W2078697485 date "1995-06-01" @default.
- W2078697485 modified "2023-10-15" @default.
- W2078697485 title "NEW PSEUDONONAPEPTIDE BOMBESIN ANTAGONISTS WITH C-TERMINAL LEU-PSI(CH2N)TAC-NH2 SHOW HIGH BINDING-AFFINITY TO BOMBESIN/GRP RECEPTORS ON CFPAC-1 HUMAN PANCREATIC-CANCER CELLS" @default.
- W2078697485 doi "https://doi.org/10.3892/ijo.6.6.1165" @default.
- W2078697485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21556653" @default.
- W2078697485 hasPublicationYear "1995" @default.
- W2078697485 type Work @default.
- W2078697485 sameAs 2078697485 @default.
- W2078697485 citedByCount "6" @default.
- W2078697485 countsByYear W20786974852014 @default.
- W2078697485 countsByYear W20786974852019 @default.
- W2078697485 countsByYear W20786974852022 @default.
- W2078697485 crossrefType "journal-article" @default.
- W2078697485 hasAuthorship W2078697485A5015546244 @default.
- W2078697485 hasAuthorship W2078697485A5019624736 @default.
- W2078697485 hasAuthorship W2078697485A5068739269 @default.
- W2078697485 hasAuthorship W2078697485A5084448804 @default.
- W2078697485 hasConcept C118303440 @default.
- W2078697485 hasConcept C12554922 @default.
- W2078697485 hasConcept C134018914 @default.
- W2078697485 hasConcept C153911025 @default.
- W2078697485 hasConcept C170493617 @default.
- W2078697485 hasConcept C185592680 @default.
- W2078697485 hasConcept C2776885963 @default.
- W2078697485 hasConcept C2776998989 @default.
- W2078697485 hasConcept C2778122271 @default.
- W2078697485 hasConcept C2778448772 @default.
- W2078697485 hasConcept C55493867 @default.
- W2078697485 hasConcept C86803240 @default.
- W2078697485 hasConceptScore W2078697485C118303440 @default.
- W2078697485 hasConceptScore W2078697485C12554922 @default.
- W2078697485 hasConceptScore W2078697485C134018914 @default.
- W2078697485 hasConceptScore W2078697485C153911025 @default.
- W2078697485 hasConceptScore W2078697485C170493617 @default.
- W2078697485 hasConceptScore W2078697485C185592680 @default.
- W2078697485 hasConceptScore W2078697485C2776885963 @default.
- W2078697485 hasConceptScore W2078697485C2776998989 @default.
- W2078697485 hasConceptScore W2078697485C2778122271 @default.
- W2078697485 hasConceptScore W2078697485C2778448772 @default.
- W2078697485 hasConceptScore W2078697485C55493867 @default.
- W2078697485 hasConceptScore W2078697485C86803240 @default.
- W2078697485 hasLocation W20786974851 @default.
- W2078697485 hasLocation W20786974852 @default.
- W2078697485 hasOpenAccess W2078697485 @default.
- W2078697485 hasPrimaryLocation W20786974851 @default.
- W2078697485 hasRelatedWork W1903466722 @default.
- W2078697485 hasRelatedWork W1964445130 @default.
- W2078697485 hasRelatedWork W2018288053 @default.
- W2078697485 hasRelatedWork W2022005705 @default.
- W2078697485 hasRelatedWork W2054240951 @default.
- W2078697485 hasRelatedWork W2078242589 @default.
- W2078697485 hasRelatedWork W2078697485 @default.
- W2078697485 hasRelatedWork W2120329938 @default.
- W2078697485 hasRelatedWork W2216580753 @default.
- W2078697485 hasRelatedWork W2261760283 @default.
- W2078697485 isParatext "false" @default.
- W2078697485 isRetracted "false" @default.
- W2078697485 magId "2078697485" @default.
- W2078697485 workType "article" @default.